Bliss GVS Pharma Limited (BLISSGVS) — Annual Report
Bliss GVS Pharma announced its 41st AGM on July 15, 2026, via video conference, with shareholders voting remotely. The meeting will adopt the audited standalone and consolidated financial statements for FY2025-26, declare a final dividend of H1 per share, and reappoint Managing Director Narsimha Shibroor Kamath. Record date for dividend eligibility is July 8, 2026, with payment due by August 14, 2026, subject to tax deduction at source.
About Bliss GVS Pharma Limited (BLISSGVS)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when BLISSGVS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BLISSGVS — Free💡 Ask AI about this filing
📊 More BLISSGVS filings
- Announcement — 15 July 2026 Bliss GVS Pharma disclosed authorized contacts for material event reporting to exchanges, listing th...
- 🟡 Board Meeting — 3 July 2026 Bliss GVS Pharma announced board approval of three key leadership changes effective July 2026: appoi...
- 🟡 Board Meeting — 3 July 2026 No summary available
- 🟡 Board Meeting — 3 July 2026 Bliss GVS Pharma announced board approval of three key changes: appointment of Santosh Parab as Addi...
- 🟡 Board Meeting — 3 July 2026 The board approved the appointment of Santosh Parab as an additional non-executive director effectiv...
🔥 Also filed on 23 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when BLISSGVS files new disclosures
Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BLISSGVS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research